U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...

COPENHAGEN (Reuters) -Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral ...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions about the causes of obesity and treatment goals.

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

Cheryl Dunye Outfit Jingletown Heads To Cannes Market With Lilly Wachowski, Lawrence Mattis, Killer Films Projects.

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

People taking Eli Lilly's obesity drug, Zepbound ... chief medical officer of knownwell, an obesity care company. Wegovy has ...